Abstract
Thyrotropin-releasing hormone (TRH)-degrading activity was investigated in human cord, maternal, and euthyroid adult sera by measuring (a) the rate of disappearance of TRH and (b) the rate of formation of degradation products. The rate of TRH degradation in cord and maternal sera was 25-33% of that in euthyroid adult serum. Concomitantly, in cord and maternal sera, the rate of formation of proline, a major TRH degradation product in serum, was one-quarter to one-third that in euthyroid adult sera. The differences were highly significant (P less than 0.001). The decreased levels of TRH-degrading activity in cord and maternal sera cannot be explained by (a) the presence of a dialyzable inhibitor, (b) the absence of an activator of TRH degradation, or (c) a reversal of the degradation process. There was no difference in the types of radioactive degradation products formed by cord, maternal, and euthyroid adult sera. The low level of TRH-degrading activity and its possible relationship to high thyrotropin-stimulating hormone levels in cord serum suggest that TRH-degrading activity may be a factor to consider in investigations of the perinatal pituitary-thyroid axis, but further studies are needed to determine the role of serum degradation of TRH in regulating physiological levels of TRH.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Abuid J., Klein A. H., Foley T. P., Jr, Larsen P. R. Total and free triiodothyronine and thyroxine in early infancy. J Clin Endocrinol Metab. 1974 Aug;39(2):263–268. doi: 10.1210/jcem-39-2-263. [DOI] [PubMed] [Google Scholar]
- Abuid J., Stinson D. A., Larsen P. R. Serum triiodothyronine and thyroxine in the neonate and the acute increases in these hormones following delivery. J Clin Invest. 1973 May;52(5):1195–1199. doi: 10.1172/JCI107286. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Anderson L. E., McClure W. O. An improved scintillation cocktail of high-solubilizing power. Anal Biochem. 1973 Jan;51(1):173–179. doi: 10.1016/0003-2697(73)90465-x. [DOI] [PubMed] [Google Scholar]
- Bassiri R., Utiger R. D. Serum inactivation of the immunological and biological activity of thyrotropin releasing hormone (TRH). Endocrinology. 1972 Sep;91(3):657–664. doi: 10.1210/endo-91-3-657. [DOI] [PubMed] [Google Scholar]
- Bauer K., Lipmann F. Attempts toward biosynthesis of the thyrotropin-releasing hormone and studies on its breakdown in hypothalamic tissue preparations. Endocrinology. 1976 Jul;99(1):230–242. doi: 10.1210/endo-99-1-230. [DOI] [PubMed] [Google Scholar]
- Bauer K. Regulation of degradation of thyrotropin releasing hormone by thyroid hormones. Nature. 1976 Feb 19;259(5544):591–593. doi: 10.1038/259591a0. [DOI] [PubMed] [Google Scholar]
- Burt D. R., Snyder S. H. Thyrotropin releasing hormone (TRH): apparent receptor binding in rat brain membranes. Brain Res. 1975 Aug 8;93(2):309–328. doi: 10.1016/0006-8993(75)90353-4. [DOI] [PubMed] [Google Scholar]
- Chopra I. J. A radioimmunoassay for measurement of 3,3',5'-triiodothyronine (reverse T3). J Clin Invest. 1974 Sep;54(3):583–592. doi: 10.1172/JCI107795. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DOWLING J. T., FREINKEL N., INGBAR S. H. Thyroxine-binding by sera of pregnant women, newborn infants, and women with spontaneous abortion. J Clin Invest. 1956 Nov;35(11):1263–1276. doi: 10.1172/JCI103381. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dupont A., Labrie F., Levasseur L., Dussault J. H., Schally A. V. Effect of thyroxine on the inactivation of thyrotrophin-releasing hormone by rat and human plasma. Clin Endocrinol (Oxf) 1976 Jul;5(4):323–330. doi: 10.1111/j.1365-2265.1976.tb01961.x. [DOI] [PubMed] [Google Scholar]
- Fisher D. A., Odell W. D. Acute release of thyrotropin in the newborn. J Clin Invest. 1969 Sep;48(9):1670–1677. doi: 10.1172/JCI106132. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gautvik K. M., Tashjian A. H., Jr, Kourides I. A., Weintraub B. D., Graeber C. T., Maloof F., Suzuki K., Zuckerman J. E. Thyrotropin-releasing hormone is not the sole physiologic mediator of prolactin release during suckling. N Engl J Med. 1974 May 23;290(21):1162–1165. doi: 10.1056/NEJM197405232902103. [DOI] [PubMed] [Google Scholar]
- Jackson I. M., Reichlin S. Thyrotropin releasing hormine (TRH): distribution in the brain, blood and urine of the rat. Life Sci. 1974 Jun 1;14(11):2259–2266. doi: 10.1016/0024-3205(74)90107-6. [DOI] [PubMed] [Google Scholar]
- Knigge K. M., Schock D. Characteristics of the plasma TRH-degrading enzyme. Neuroendocrinology. 1975;19(3):277–287. [PubMed] [Google Scholar]
- McKelvy J. F. A rapid and quantitative procedure for the purification of picomole quantities of salt-free synthetic (3-H-Pro) thyrotropin releasing hormone. Anal Biochem. 1975 Apr;64(2):609–614. doi: 10.1016/0003-2697(75)90475-3. [DOI] [PubMed] [Google Scholar]
- McKelvy J. F., LeBlanc P., Laudes C., Perrie S., Grimm-Jorgensen Y., Kordon C. The use of bacitracin as an inhibitor of the degradation of thyrotropin releasing factor and luteinizing hormone releasing factor. Biochem Biophys Res Commun. 1976 Nov 22;73(2):507–515. doi: 10.1016/0006-291x(76)90736-1. [DOI] [PubMed] [Google Scholar]
- Neary J. T., Kieffer J. D., Federico P., Mover H., Maloof F., Soodak M. Thyrotropin releasing hormone: development of inactivation system during maturation of the rat. Science. 1976 Jul 30;193(4251):403–405. doi: 10.1126/science.819993. [DOI] [PubMed] [Google Scholar]
- Oliver C., Eskay R. L., Ben-Jonathan N., Porter J. C. Distribution and concentration of TRH in the rat brain. Endocrinology. 1974 Aug;95(2):540–546. doi: 10.1210/endo-95-2-540. [DOI] [PubMed] [Google Scholar]
- Redding T. W., Schally A. V. On the half life of thyrotropin-releasing hormone in rats. Neuroendocrinology. 1972;9(4):250–256. doi: 10.1159/000122056. [DOI] [PubMed] [Google Scholar]
- Redding T. W., Schally A. V. Studies on the inactivation of thyrotropin-releasing hormone (TRH). Proc Soc Exp Biol Med. 1969 Jun;131(2):415–420. doi: 10.3181/00379727-131-33891. [DOI] [PubMed] [Google Scholar]
- Ridgway E. C., Weintraub B. D., Cevallos J. L., Rack M. C., Maloof F. Suppression of pituitary TSH secretion in the patient with a hyperfunctioning thyroid nodule. J Clin Invest. 1973 Nov;52(11):2783–2792. doi: 10.1172/JCI107474. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Taylor W. L., Dixon J. E. The inhibition of thyrotropin-releasing hormone deamidation in porcine hypothalamic tissues. Biochim Biophys Acta. 1976 Sep 24;444(2):428–434. doi: 10.1016/0304-4165(76)90386-x. [DOI] [PubMed] [Google Scholar]
- Vale W. W., Burgus R., Dunn T. F., Guillemin R. In vitro plasma inactivation of thyrotropin releasing factor (TRF) and related peptides. Its inhibition by various means and by the synthetic dipeptide PCA-His-OME. Hormones. 1971;2(4):193–203. doi: 10.1159/000178234. [DOI] [PubMed] [Google Scholar]
- White N., Jeffcoate S. L., Griffiths E. C., Hooper K. C. Effect of thyroid status on the thyrotrophin-releasing hormone-degrading activity of rat serum. J Endocrinol. 1976 Oct;71(1):13–19. doi: 10.1677/joe.0.0710013. [DOI] [PubMed] [Google Scholar]
- Winokur A., Utiger R. D. Thyrotropin-releasing hormone: regional distribution in rat brain. Science. 1974 Jul 19;185(4147):265–267. doi: 10.1126/science.185.4147.265. [DOI] [PubMed] [Google Scholar]
- Winters A. J., Eskay R. L., Porter J. C. Concentration and distribution of TRH and LRH in the human fetal brain. J Clin Endocrinol Metab. 1974 Nov;39(5):960–963. doi: 10.1210/jcem-39-5-960. [DOI] [PubMed] [Google Scholar]
